BeiGene(BGNE)
China - BeijingBiotechnology
Focus: BeiGene is a 10,000+ employee public biotechnology company headquartered in Beijing with a robust clinical pipeline focused on oncology and immunotherapy. The company operates as a mid-to-large cap biotech with global clinical trial infrastructure.
Profile data last refreshed 17h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Employees
10001+
Open Jobs
262-4 this month
Stable — net -4 jobs in 30d
305 added, 309 removed. Backfill posture.
Should You Work at BeiGene?
AI assessmentStrong career opportunity for early-to-mid stage pharma professionals willing to bet on clinical execution in oncology, but limited near-term revenue catalysts create execution risk.
Why Work Here
- Diversified pipeline with 22 active programs across Phase 1-3, including 3 Phase 3 trials with near-term regulatory catalysts
- Aggressive hiring across Clinical Operations (50 roles) and Commercial (47 roles) signals confidence in pipeline advancement and market expansion
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Late-stage
5 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
First line therapy
CLL/SLLClinical Trials (1)
NCT05590702French Observational Study of Patients With Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma in Real-World Settings
N/AHelp build intelligence for BeiGene
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.